Synchron

We’re excited to announce our $200M Series D fundraise led by Double Point Ventures, with @khoslaventures, ARCH Ventures, Bezos Expeditions, NRF, NTI, METIS, @protocollabs @K5Global and others. 🧠🧠 Read the release: businesswire.com/news/home/2025…

Synchron bags $200M to advance thought-control tech @synchroninc #neurology #paralysis #Funding firstwordhealthtech.com/story/6517684

Neuralink rival company @synchroninc just raised $200 million. Their CEO @tomoxl joined TITV to explain his plans. Watch the full episode: thein.fo/47KvWjM

Neuralink rival Synchron raises $200M for brain implant #Echobox=1762445289" target="_blank" rel="nofollow noopener">crainsnewyork.com/health-pulse/s…

Company targets pivotal trials of brain-computer interface platform that allows control of digital devices using thought alone. longevity.technology/news/synchron-… #neurotech #longevity #investment #BCI #technology

Neuralink rival Synchron raises $200M for brain implant. #Echobox=1762447849-4" target="_blank" rel="nofollow noopener">modernhealthcare.com/health-tech/mh…

We’re excited to announce our $200M Series D fundraise led by Double Point Ventures, with @khoslaventures, ARCH Ventures, Bezos Expeditions, NRF, NTI, METIS, @protocollabs @K5Global and others. 🧠🧠 Read the release: businesswire.com/news/home/2025…

Our CEO @tomoxl will be on @theinformation TITV today at 8 am PT/11 am ET. Check the stream!

Synchron raised $200 million to advance its work building brain implants that doctors can insert through blood vessels bloomberg.com/news/articles/…

Markets eye a potential tariff rollback while Evommune and @Aeromexico will make their Wall Street debuts on the NYSE. Elsewhere, @synchroninc announces it raised $200 Million in Series D funding. @Ash_TV has more in the market update. ➡️ Follow @NYSE for the daily Market Update

We’re excited to return as exhibitors at #ALSNexus2025, hosted by @alsassociation, an event where leaders across research, care, and advocacy come together to drive progress for the #ALS community. Meet us at Booth #102. More info: lnkd.in/esBiXEwe

During @theCUBE + @NYSE Wired: Medtech Unplugged Series, @dvellante spoke to @KurtHaggstrom about @Synchroninc’s Brain Computer Interface (BCI) & how it’s less invasive, & more scalable & durable than Neuralink. 💡 More insights: thecube.net/events/nyse/me… @furrier @bjbaumann2014

Synchron combines brain implant with @Apple's BCI protocol to enable control of consumer electronic devices via neural signals. longevity.technology/news/als-patie… #longevity #neurotech #BCI #iPad #ALS

You can officially control an Apple device with your thoughts, as long as you have the Stentrode brain implant made by NYC-based Synchron. pcmag.com/news/first-loo…

Synchron Debuts the First Thought-Controlled iPad Experience using Apple’s New BCI Human Interface Device Protocol tinyurl.com/3krbp25h

Apple's new thought control protocol has now been shown in use by Synchron, a medical company that has made a prototype for using iPads solely by thinking. By @WGallagher appleinsider.com/articles/25/08…

In a remarkable first, Synchron has revealed the world’s first public demonstration of an iPad controlled purely by thought. thedebrief.org/synchron-unvei…

Synchron is the first company to connect its brain-computer interfaces to Apple products, and a video shows it in action for the first time—with one innovative new feature we didn't expect. pcmag.com/news/first-loo…

🧠 For the first time ever, an individual was able to control their iPad entirely by thought, enabled by @Apple’s new #BCI HID protocol and accessibility features. Thank you, Mark and to the team at Apple for driving the world of #accessibility and technology forward. 🔗 Read the full release: shorturl.at/oyOk7 Watch the video: youtu.be/YK8r5vdpozA #BCI #Neurotechnology #Accessibility

Thanks @WIRED @emilylmullin for sharing Mark’s story and what our team has been working on. 🧠🧠 #BCI wired.com/story/synchron…